本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evaxion Biotech A/S

2.81
-0.1900-6.33%
成交量:9.99万
成交额:28.51万
市值:2,535.04万
市盈率:-2.58
高:2.99
开:2.98
低:2.78
收:3.00
52周最高:12.15
52周最低:2.77
股本:902.15万
流通股本:636.06万
量比:3.24
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):-1.0886
每股收益(LYR):-1.2027
净资产收益率:-109.86%
总资产收益率:-25.97%
市净率:2.66
市盈率(LYR):-2.34

数据加载中...

2026/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/21

SEC问询函

Form CORRESP - Correspondence
2025/01/29

SEC问询函

Form CORRESP - Correspondence
2025/01/28

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/05

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/11/18

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/20

SEC问询函

Form CORRESP - Correspondence
2024/08/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/07/22

SEC问询函

Form CORRESP - Correspondence
2024/07/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/31

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/31

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/30

SEC问询函

Form CORRESP - Correspondence